33
/it/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
August 1, 2025
Public Timelines
Menu
Public Timelines
FAQ
Public Timelines
FAQ
For education
For educational institutions
For teachers
For students
Cabinet
For educational institutions
For teachers
For students
Open cabinet
Creare
Close
Create a timeline
Public timelines
Library
FAQ
Modificare
Scaricare
Export
Creare una copia
Premium
Integrare nel sito Web
Share
End dates of pivitol studies
Category:
Altro
è stato aggiornato:
5 nov 2018
0
0
352
Autori
Created by
letrishka
Attachments
Comments
Payload timeline
By
letrishka
3 set 2018
0
0
466
Eventi
Anetumab ravtansine Mesothelioma
Mirvetuximab soravtansine
Polatuzumab vedotin Diffues large B-cell lymphoma
Enfortumab vedotin Urothelial bladder cancer
Trastuzumab duocarmazine HER-2+ve breast cancer
Trastuzumab deruxtecan Breast cancer
Depatuxizumab mafodotin Glioblastoma
Mirvetuximab soravtansine Ovarian cancer (PROC)
Sacituzumab govitecan Triple negative breast cancer (TBNC)
Rova-T (TRINITY) Small cell lung cancer
About & Feedback
Accordo
Privatezza
Biblioteca
FAQ
Support 24/7
Cabinet
Get premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Comments